ZUSAMMENSETZUNG

European patent · EP2734186 · Deleted

Register entry

Publication number
EP2734186
Application number
EP12740119
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 19, 2012
Published
May 28, 2014
Granted
Sep 12, 2018
Deleted
Jul 31, 2020
Reason
Annual fee unpaid
IPC classes
A61K 9/00 (2006.01)
A61K 31/522 (2006.01)
A61P 11/06 (2006.01)
A61P 37/08 (2006.01)
Priority
US 201161510624 P 22.07.2011
PCT application
PCT/EP2012/064139 19.07.2012
PCT publication
WO2013/014052 31.01.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 17, 2021

    Deleted, fee unpaid

    Published in Swissreg on 17.02.2021

  2. Oct 6, 2018

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 06.10.2018

  3. Sep 12, 2018

    Granted

    Published in Swissreg on 12.09.2018

Parties

Holder

GlaxoSmithKline LLC

251 Little Falls Drive, Wilmington, DE 19808, US

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

AMBERY, Claire Louise

Uxbridge Middlesex UB11 1BT, GB

EDWARDS, Christopher David

Stevenage Hertfordshire SG1 2NY, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.